There are many treatment options for ADHD and even more studies behind them. Experts disagree at times on which treatments to recommend.
This study aimed to determine which treatments work best and which cause the mildest side effects.
Since ADHD can be different in adults and children, researchers also looked to see whether treatments work differently in adults and children.
The benefits and safety of medications for attention-deficit hyperactivity disorder (ADHD) remain controversial, and guidelines are inconsistent on which medications are preferred across different age groups. We aimed to estimate the comparative efficacy and tolerability of oral medicati...
The authors combined data from 133 clinical trials covering 18,199 children and adults. These studies were randomized and double-blinded, the gold standard of medical research.
They analyzed how well each drug worked in reducing ADHD symptoms within the first year.
They calculated differences in effectiveness between different drugs and the odds of patients having intolerable side effects from the drugs.
We did a literature search for published and unpublished double-blind randomised controlled trials comparing amphetamines (including lisdexamfetamine), atomoxetine, bupropion, clonidine, guanfacine, methylphenidate, and modafinil with each other or placebo. We systematically contacted st...
In children and teenagers, Adderall and Ritalin tended to work the best, though Strattera worked quite nicely as well.
These data were obtained from third-party observations and notes from the patients' doctors.
Of note, when teachers were surveyed, only studies with Ritalin and Provigil showed statistically significant improvements over the control group.
For ADHD core symptoms rated by clinicians in children and adolescents closest to 12 weeks, all included drugs were superior to placebo (eg, SMD -1·02, 95% CI -1·19 to -0·85 for amphetamines, -0·78, -0·93 to -0·62 for methylphenidate, -0·56, -0·66 to -0·45 for atomoxetine)...
In adults, Adderall, Ritalin, Wellbutrin, and Strattera proved to be highly effective in reducing ADHD symptoms across different clinical trials. Adderall was consistently better than the rest of the medications.
Provigil, in adults, did not show significant improvement in all studies. It doesn't necessarily mean that the drug doesn't work, but it does suggest that the data so far is inconsistent for Provigil in adults.
In adults (clinicians’ ratings), amphetamines (SMD –0·79, 95% CI –0·99 to –0·58), methylphenidate (–0·49, –0·64 to –0·35), bupropion (–0·46, –0·85 to –0·07), and atomoxetine (–0·45, –0·58 to –0·32), but not modafinil (0·16, –0·28 to 0·59), were better than placebo.
In terms of side effects, there was precise data showing that children had significantly more intolerable side effects on Adderall (amphetamines) and Intuniv (guanfacine).
The other medications here, including Ritalin, also cause side effects, but the data across the different studies were less consistent.
With respect to tolerability, amphetamines were inferior to placebo in both children and adolescents (odds ratio [OR] 2·30, 95% CI 1·36–3·89) and adults (3·26, 1·54–6·92); guanfacine was inferior to placebo in children and adolescents only (2·64, 1·20–5·81); and atomoxetine (2·33, 1·28–4...
Provigil, Adderall, Ritalin, and Strattera all caused significant side effects in adults.
Adults given these medications were significantly more likely to drop out of the study due to side effects than the control group.
The margins of error in this analysis are too large to draw definite conclusions about which one is better.
The data in this study suggest that doctors may want to try Ritalin first in children and Adderall first in adults.
This is based on a comprehensive analysis of the best data available as of 2018.
But, as you can tell from the charts, there's still a lot of ambiguity about which medication works better. Different people may also experience each drug differently.
If you have ADHD or suspect that you may have ADHD, talk to your doctor about which medication may work best.
Our findings represent the most comprehensive available evidence base to inform patients, families, clinicians, guideline developers, and policymakers on the choice of ADHD medications across age groups. Taking into account both efficacy and safety, evidence from this meta-analysis suppo...